Karyopharm Therapeutics Inc. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Karyopharm Therapeutics Inc. for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2020 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Option Exercise | M | 0.03 | 3,030 | 100 | 0 | |
| Mar 17 2020 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Buy | M | 0.03 | 3,030 | 100 | 6,030 | 3 K to 6 K (+101.00 %) |
| Mar 17 2020 | KPTI | Karyopharm Therape ... | DEMAREE JOHN | Chief Commercial Of ... | Option Exercise | A | 16.50 | 151,200 | 2,494,800 | 151,200 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 366,061 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 410,303 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.64 | 2,068 | 46,821 | 555,122 | 557.2 K to 555.1 K (-0.37 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.11 | 7,932 | 175,365 | 557,190 | 565.1 K to 557.2 K (-1.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 565,122 | 555.1 K to 565.1 K (+1.80 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.38 | 3,000 | 67,141 | 756,489 | 759.5 K to 756.5 K (-0.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.58 | 7,000 | 158,054 | 759,489 | 766.5 K to 759.5 K (-0.91 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 766,489 | 756.5 K to 766.5 K (+1.32 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 410,303 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 366,061 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.38 | 3,000 | 67,141 | 756,489 | 759.5 K to 756.5 K (-0.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.58 | 7,000 | 158,054 | 759,489 | 766.5 K to 759.5 K (-0.91 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 766,489 | 756.5 K to 766.5 K (+1.32 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.64 | 2,068 | 46,821 | 555,122 | 557.2 K to 555.1 K (-0.37 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.11 | 7,932 | 175,365 | 557,190 | 565.1 K to 557.2 K (-1.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 565,122 | 555.1 K to 565.1 K (+1.80 %) |
| Mar 09 2020 | KPTI | Karyopharm Therape ... | Paulson Richard A. | Director | Option Exercise | A | 26.12 | 50,000 | 1,306,000 | 50,000 | |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 26,500 | 275,335 | 76,500 | |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 24.00 | 9,000 | 216,029 | 10,367 | 19.4 K to 10.4 K (-46.47 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 28.00 | 10,000 | 280,000 | 19,367 | 29.4 K to 19.4 K (-34.05 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 23.50 | 7,500 | 176,250 | 29,367 | 36.9 K to 29.4 K (-20.34 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 26,500 | 275,335 | 36,867 | 10.4 K to 36.9 K (+255.62 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 8.06 | 5,000 | 40,300 | 0 | |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 23.50 | 5,000 | 117,500 | 0 | 5 K to 0 (-100.00 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 8.06 | 5,000 | 40,300 | 5,000 | 0 to 5 K |